[ Price : $8.95]
Viiv Healthcare says it is submitting an NDA for a combination HIV-1 drug based on its Tivicay and two other antiretrovirals.[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Capillus, Dolphin Intertrade, Omid Nassam, R82 A/S. Dimitri Sirakoff, USP Labs, ...[ Price : $8.95]
FDA approves a Lupin supplemental NDA for Antara (fenofibrate) capsules in 30 mg and 90 mg strengths, indicated for treating patie...[ Price : $8.95]
FDA warns Northern Digital about Quality System and Medical Device Reporting violations in its manufacturing of reflective passive...[ Price : $8.95]
Generic drug manufacturers tell the World Health Organization that biosimilars should be given the same non-proprietary name as th...[ Price : $8.95]
FDA medical reviewers says Janssens experimental hepatitis C drug simeprevir appears to be effective but has some side effects.[ Price : $8.95]
Cubist Pharmaceuticals submits an NDA for its investigational antibiotic tedizolid phosphate, indicated for treating acute bacteri...[ Price : $8.95]
Durect Corp. says its development partner Pfizer will continue the development program for Remoxy (oxycodone) extended-release cap...